Clinical Trial Update: Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial registry entry describing a chemo-immunotherapy study in patients under 18 with bone sarcoma and soft tissue sarcomas, including embryo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Rhabdomyosarcoma
• Bone Sarcoma
• Embryonal Rhabdomyosarcoma
• Soft Tissue Sarcoma

Snippet

Sponsor: N.N. Petrov National Medical Research Center of Oncology | Conditions: Bone Sarcoma, Embryonal Rhabdomyosarcoma | Phase 3 | Status: RECRUITING